Cargando…

Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers

BACKGROUND: Heparin-binding protein (HBP) is released by neutrophils upon activation, and elevated plasma levels are seen in inflammatory states like sepsis, shock, cardiac arrest, and burns. However, little is known about the elimination of HBP. We wanted to study renal clearance of HBP in healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuelsson, Line, Tydén, Jonas, Herwald, Heiko, Hultin, Magnus, Walldén, Jakob, Steinvall, Ingrid, Sjöberg, Folke, Johansson, Joakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715206/
https://www.ncbi.nlm.nih.gov/pubmed/31465432
http://dx.doi.org/10.1371/journal.pone.0221813
_version_ 1783447196847308800
author Samuelsson, Line
Tydén, Jonas
Herwald, Heiko
Hultin, Magnus
Walldén, Jakob
Steinvall, Ingrid
Sjöberg, Folke
Johansson, Joakim
author_facet Samuelsson, Line
Tydén, Jonas
Herwald, Heiko
Hultin, Magnus
Walldén, Jakob
Steinvall, Ingrid
Sjöberg, Folke
Johansson, Joakim
author_sort Samuelsson, Line
collection PubMed
description BACKGROUND: Heparin-binding protein (HBP) is released by neutrophils upon activation, and elevated plasma levels are seen in inflammatory states like sepsis, shock, cardiac arrest, and burns. However, little is known about the elimination of HBP. We wanted to study renal clearance of HBP in healthy individuals and in burn patients in intensive care units (ICUs). We also wished to examine the levels of HBP in the effluent of renal replacement circuits in ICU patients undergoing continuous renal replacement therapy (CRRT). METHODS: We measured plasma and urine levels of HBP and urine flow rate in 8 healthy individuals and 20 patients in a burn ICU. In 32 patients on CRRT, we measured levels of HBP in plasma and in the effluent of the CRRT circuit. RESULTS: Renal clearance of HBP (median (IQR) ml/min) was 0.19 (0.08–0.33) in healthy individuals and 0.30 (0.01–1.04) in burn ICU patients. In ICU patients with cystatin C levels exceeding 1.44 mg/l, clearance was 0.45 (0.15–2.81), and in patients with cystatin C below 1.44 mg/l clearance was lower 0.28 (0.14–0.55) (p = 0.04). Starting CRRT did not significantly alter plasma levels of HBP (p = 0.14), and the median HBP level in the effluent on CRRT was 9.1 ng/ml (IQR 7.8–14.4 ng/ml). CONCLUSION: In healthy individuals and critically ill burn patients, renal clearance of HBP is low. It is increased when renal function is impaired. Starting CRRT in critically ill patients does not alter plasma levels of HBP significantly, but HBP can be found in the effluent. It seems unlikely that impaired kidney function needs to be considered when interpreting concentrations of HBP in previous studies. Starting CRRT does not appear to be an effective way of reducing HBP concentrations.
format Online
Article
Text
id pubmed-6715206
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67152062019-09-10 Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers Samuelsson, Line Tydén, Jonas Herwald, Heiko Hultin, Magnus Walldén, Jakob Steinvall, Ingrid Sjöberg, Folke Johansson, Joakim PLoS One Research Article BACKGROUND: Heparin-binding protein (HBP) is released by neutrophils upon activation, and elevated plasma levels are seen in inflammatory states like sepsis, shock, cardiac arrest, and burns. However, little is known about the elimination of HBP. We wanted to study renal clearance of HBP in healthy individuals and in burn patients in intensive care units (ICUs). We also wished to examine the levels of HBP in the effluent of renal replacement circuits in ICU patients undergoing continuous renal replacement therapy (CRRT). METHODS: We measured plasma and urine levels of HBP and urine flow rate in 8 healthy individuals and 20 patients in a burn ICU. In 32 patients on CRRT, we measured levels of HBP in plasma and in the effluent of the CRRT circuit. RESULTS: Renal clearance of HBP (median (IQR) ml/min) was 0.19 (0.08–0.33) in healthy individuals and 0.30 (0.01–1.04) in burn ICU patients. In ICU patients with cystatin C levels exceeding 1.44 mg/l, clearance was 0.45 (0.15–2.81), and in patients with cystatin C below 1.44 mg/l clearance was lower 0.28 (0.14–0.55) (p = 0.04). Starting CRRT did not significantly alter plasma levels of HBP (p = 0.14), and the median HBP level in the effluent on CRRT was 9.1 ng/ml (IQR 7.8–14.4 ng/ml). CONCLUSION: In healthy individuals and critically ill burn patients, renal clearance of HBP is low. It is increased when renal function is impaired. Starting CRRT in critically ill patients does not alter plasma levels of HBP significantly, but HBP can be found in the effluent. It seems unlikely that impaired kidney function needs to be considered when interpreting concentrations of HBP in previous studies. Starting CRRT does not appear to be an effective way of reducing HBP concentrations. Public Library of Science 2019-08-29 /pmc/articles/PMC6715206/ /pubmed/31465432 http://dx.doi.org/10.1371/journal.pone.0221813 Text en © 2019 Samuelsson et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Samuelsson, Line
Tydén, Jonas
Herwald, Heiko
Hultin, Magnus
Walldén, Jakob
Steinvall, Ingrid
Sjöberg, Folke
Johansson, Joakim
Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers
title Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers
title_full Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers
title_fullStr Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers
title_full_unstemmed Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers
title_short Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers
title_sort renal clearance of heparin-binding protein and elimination during renal replacement therapy: studies in icu patients and healthy volunteers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715206/
https://www.ncbi.nlm.nih.gov/pubmed/31465432
http://dx.doi.org/10.1371/journal.pone.0221813
work_keys_str_mv AT samuelssonline renalclearanceofheparinbindingproteinandeliminationduringrenalreplacementtherapystudiesinicupatientsandhealthyvolunteers
AT tydenjonas renalclearanceofheparinbindingproteinandeliminationduringrenalreplacementtherapystudiesinicupatientsandhealthyvolunteers
AT herwaldheiko renalclearanceofheparinbindingproteinandeliminationduringrenalreplacementtherapystudiesinicupatientsandhealthyvolunteers
AT hultinmagnus renalclearanceofheparinbindingproteinandeliminationduringrenalreplacementtherapystudiesinicupatientsandhealthyvolunteers
AT walldenjakob renalclearanceofheparinbindingproteinandeliminationduringrenalreplacementtherapystudiesinicupatientsandhealthyvolunteers
AT steinvallingrid renalclearanceofheparinbindingproteinandeliminationduringrenalreplacementtherapystudiesinicupatientsandhealthyvolunteers
AT sjobergfolke renalclearanceofheparinbindingproteinandeliminationduringrenalreplacementtherapystudiesinicupatientsandhealthyvolunteers
AT johanssonjoakim renalclearanceofheparinbindingproteinandeliminationduringrenalreplacementtherapystudiesinicupatientsandhealthyvolunteers